The American pharmaceutical company Novavax, which specializes in the production of antibiotics, plans to release 1 billion doses of the coronavirus vaccine under development in the Czech Republic. The Prime Minister of the Republic, Andrei Babish announced told journalists on Tuesday.
“Novavax intends to produce a total of two billion doses of vaccines against coronavirus, he said. – About 300 of our fellow citizens will be able to participate in clinical tests. They will be selected from among the volunteers. ”
According to Babiš, Vaccine will be produced at the Praha Vaccines pharmaceutical plant, located in the Kostelec nad Cernim Lesi area, a few kilometers east of Prague. The clinical phase of drug trials should begin in October.
After the successful completion of clinical trials, the Czech authorities intend to conclude a contract with an American company to supply a vaccine. Drug development involves Novavax facilities in the Czech Republic, the USA, and Sweden.
The Czech Republic has previously joined the European Commission (EC) initiative to purchase coronavirus vaccines for all EU member states centrally. The EC is in talks on this with pharmaceutical companies AstraZeneca, Sanofi, Johnson & Johnson, BioNTech / Pfizer, CureVac, and Moderna. Residents of the community countries are expected to be vaccinated free of charge.